OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Occurrence of multi-carbapenemases producers among carbapenemase-producing Enterobacterales and in vitro activity of combinations including cefiderocol, ceftazidime-avibactam, meropenem-vaborbactam, and aztreonam in the COVID-19 era
Gabriele Bianco, Matteo Boattini, Sara Comini, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2022) Vol. 41, Iss. 4, pp. 573-580
Open Access | Times Cited: 38
Gabriele Bianco, Matteo Boattini, Sara Comini, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2022) Vol. 41, Iss. 4, pp. 573-580
Open Access | Times Cited: 38
Showing 1-25 of 38 citing articles:
ESKAPE and Beyond: The Burden of Coinfections in the COVID-19 Pandemic
Miguel Ángel Loyola-Cruz, Luis Uriel Gonzalez-Avila, Arturo Martínez-Trejo, et al.
Pathogens (2023) Vol. 12, Iss. 5, pp. 743-743
Open Access | Times Cited: 32
Miguel Ángel Loyola-Cruz, Luis Uriel Gonzalez-Avila, Arturo Martínez-Trejo, et al.
Pathogens (2023) Vol. 12, Iss. 5, pp. 743-743
Open Access | Times Cited: 32
Rapid evolution of pan-β-lactam resistance in Enterobacterales co-producing KPC and NDM: insights from global genomic analysis after the COVID-19 pandemic
Fábio P. Sellera, Nilton Lincopán, Danny Fuentes‐Castillo, et al.
The Lancet Microbe (2024) Vol. 5, Iss. 5, pp. e412-e413
Open Access | Times Cited: 9
Fábio P. Sellera, Nilton Lincopán, Danny Fuentes‐Castillo, et al.
The Lancet Microbe (2024) Vol. 5, Iss. 5, pp. e412-e413
Open Access | Times Cited: 9
In vitro activity of cefiderocol against European Enterobacterales, including isolates resistant to meropenem and recentβ-lactam/β-lactamase inhibitor combinations
Anne Santerre Henriksen, Fabio Arena, Marie Attwood, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 8
Open Access | Times Cited: 9
Anne Santerre Henriksen, Fabio Arena, Marie Attwood, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 8
Open Access | Times Cited: 9
Disc Diffusion and ComASP® Cefiderocol Microdilution Panel to Overcome the Challenge of Cefiderocol Susceptibility Testing in Clinical Laboratory Routine
Gabriele Bianco, Matteo Boattini, Sara Comini, et al.
Antibiotics (2023) Vol. 12, Iss. 3, pp. 604-604
Open Access | Times Cited: 19
Gabriele Bianco, Matteo Boattini, Sara Comini, et al.
Antibiotics (2023) Vol. 12, Iss. 3, pp. 604-604
Open Access | Times Cited: 19
Global emergence of carbapenem-resistant Klebsiella pneumoniae co-carrying multiple carbapenemases
Hao Guo, Yuye Wu, Lirong Li, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 3557-3563
Open Access | Times Cited: 17
Hao Guo, Yuye Wu, Lirong Li, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 3557-3563
Open Access | Times Cited: 17
Aztreonam Combinations with Avibactam, Relebactam, and Vaborbactam as Treatment for New Delhi Metallo-β-Lactamase-Producing Enterobacterales Infections—In Vitro Susceptibility Testing
Małgorzata Brauncajs, Filip Bielec, Marlena Malinowska, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 383-383
Open Access | Times Cited: 7
Małgorzata Brauncajs, Filip Bielec, Marlena Malinowska, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 383-383
Open Access | Times Cited: 7
Antimicrobial and Diagnostic Stewardship of the Novel β-Lactam/β-Lactamase Inhibitors for Infections Due to Carbapenem-Resistant Enterobacterales Species and Pseudomonas aeruginosa
Stefanos Ferous, Cleo Anastassopoulou, Vassiliki Pitiriga, et al.
Antibiotics (2024) Vol. 13, Iss. 3, pp. 285-285
Open Access | Times Cited: 6
Stefanos Ferous, Cleo Anastassopoulou, Vassiliki Pitiriga, et al.
Antibiotics (2024) Vol. 13, Iss. 3, pp. 285-285
Open Access | Times Cited: 6
Changing Epidemiology of Carbapenemases Among Carbapenem-Resistant Enterobacterales in a Greek Tertiary Care Hospital in Athens, 2020 to 2023
Vasiliki Koumaki, Eleni Voudanta, Aikaterini Michelaki, et al.
Antibiotics (2025) Vol. 14, Iss. 3, pp. 239-239
Open Access
Vasiliki Koumaki, Eleni Voudanta, Aikaterini Michelaki, et al.
Antibiotics (2025) Vol. 14, Iss. 3, pp. 239-239
Open Access
Characterization of blaKPC-2 and blaNDM-1 Plasmids of a K. pneumoniae ST11 Outbreak Clone
Camila Maria dos Santos Boralli, Julián Paganini, Rodrigo Meneses, et al.
Antibiotics (2023) Vol. 12, Iss. 5, pp. 926-926
Open Access | Times Cited: 12
Camila Maria dos Santos Boralli, Julián Paganini, Rodrigo Meneses, et al.
Antibiotics (2023) Vol. 12, Iss. 5, pp. 926-926
Open Access | Times Cited: 12
Multicenter study on the prevalence of colonization due to carbapenem-resistant Enterobacterales strains before and during the first year of COVID-19, Italy 2018–2020
Teresa Fasciana, Alberto Antonelli, Gabriele Bianco, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 12
Teresa Fasciana, Alberto Antonelli, Gabriele Bianco, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 12
Investigation of antimicrobial resistance patterns and molecular typing of Pseudomonas aeruginosa isolates among Coronavirus disease-19 patients
Somaye Shiralizadeh, Fariba Keramat, Seyyed Hamid Hashemi, et al.
BMC Microbiology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Somaye Shiralizadeh, Fariba Keramat, Seyyed Hamid Hashemi, et al.
BMC Microbiology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Assessment of the activity and mechanisms of resistance to cefiderocol and combinations of β-lactams and the novel β-lactamase inhibitors avibactam, taniborbactam, zidebactam, nacubactam, xeruborbactam, and ANT3310 in emerging double-carbapenemase-producing Enterobacterales
Tania Blanco-Martín, Inmaculada López-Hernández, Belén Aracil, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 11
Closed Access | Times Cited: 3
Tania Blanco-Martín, Inmaculada López-Hernández, Belén Aracil, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 11
Closed Access | Times Cited: 3
Emergence of carbapenem‐resistant Klebsiella pneumoniae species complex from agrifood systems: detection of ST6326 co‐producing KPC ‐2 and NDM ‐1
João Pedro Rueda Furlan, Rafael da Silva Rosa, Micaela Santana Ramos, et al.
Journal of the Science of Food and Agriculture (2024) Vol. 104, Iss. 12, pp. 7347-7354
Closed Access | Times Cited: 2
João Pedro Rueda Furlan, Rafael da Silva Rosa, Micaela Santana Ramos, et al.
Journal of the Science of Food and Agriculture (2024) Vol. 104, Iss. 12, pp. 7347-7354
Closed Access | Times Cited: 2
Evaluation of Aztreonam and Ceftazidime/Avibactam Synergism against Klebsiella pneumoniae by MALDI-TOF MS
Camila Mörschbächer Wilhelm, Éverton Inamine, Andreza Francisco Martins, et al.
Antibiotics (2023) Vol. 12, Iss. 6, pp. 1063-1063
Open Access | Times Cited: 5
Camila Mörschbächer Wilhelm, Éverton Inamine, Andreza Francisco Martins, et al.
Antibiotics (2023) Vol. 12, Iss. 6, pp. 1063-1063
Open Access | Times Cited: 5
In Vitro Activity of “Old” and “New” Antimicrobials against the Klebsiella pneumoniae Complex
Alicja Sękowska
Antibiotics (2024) Vol. 13, Iss. 2, pp. 126-126
Open Access | Times Cited: 1
Alicja Sękowska
Antibiotics (2024) Vol. 13, Iss. 2, pp. 126-126
Open Access | Times Cited: 1
In vitro activity of meropenem-vaborbactam plus aztreonam against metallo-β-lactamase-producing Klebsiella pneumoniae
Astrid V. Cienfuegos-Gallet, Elena Shashkina, Tingyu Chu, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 4
Closed Access | Times Cited: 1
Astrid V. Cienfuegos-Gallet, Elena Shashkina, Tingyu Chu, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 4
Closed Access | Times Cited: 1
Virulent Klebsiella pneumoniae ST11 clone carrying blaKPC and blaNDM from patients with and without COVID-19 in Brazil
Maria Izabely Silva Pimentel, Elizabeth Maria Bispo Beltrão, Érica Maria de Oliveira, et al.
Journal of Applied Microbiology (2024) Vol. 135, Iss. 4
Closed Access | Times Cited: 1
Maria Izabely Silva Pimentel, Elizabeth Maria Bispo Beltrão, Érica Maria de Oliveira, et al.
Journal of Applied Microbiology (2024) Vol. 135, Iss. 4
Closed Access | Times Cited: 1
Are low-income and middle-income countries being neglected in genomic surveillance of the emergence and spread of multidrug-resistant Enterobacterales?
Dennis Nurjadi, Sébastien Boutin, Thirumalaisamy P. Velavan
The Lancet Microbe (2024) Vol. 5, Iss. 8, pp. 100854-100854
Open Access | Times Cited: 1
Dennis Nurjadi, Sébastien Boutin, Thirumalaisamy P. Velavan
The Lancet Microbe (2024) Vol. 5, Iss. 8, pp. 100854-100854
Open Access | Times Cited: 1
Occurrence of multi-carbapenemase-producing Enterobacterales in a tertiary hospital in Madrid (Spain): A new epidemiologic scenario
M. Vallejo, Marta Hernández-García, Ainhize Maruri-Aransolo, et al.
Journal of Global Antimicrobial Resistance (2024) Vol. 38, pp. 281-291
Open Access | Times Cited: 1
M. Vallejo, Marta Hernández-García, Ainhize Maruri-Aransolo, et al.
Journal of Global Antimicrobial Resistance (2024) Vol. 38, pp. 281-291
Open Access | Times Cited: 1
Pharmacokinetics, Safety and Tolerability of Single-dose or Multiple-dose Cefiderocol in Hospitalized Pediatric Patients Three Months to Less Than Eighteen Years Old With Infections Treated With Standard-of-care Antibiotics in the PEDI-CEFI Phase 2 Study
John S. Bradley, Elaine Orchiston, Simon Portsmouth, et al.
The Pediatric Infectious Disease Journal (2024)
Closed Access | Times Cited: 1
John S. Bradley, Elaine Orchiston, Simon Portsmouth, et al.
The Pediatric Infectious Disease Journal (2024)
Closed Access | Times Cited: 1
Colonization and Healthcare-Associated Infection of Carbapenem-Resistant Enterobacteriaceae, Data from Polish Hospital with High Incidence of Carbapenem-Resistant Enterobacteriaceae, Does Active Target Screening Matter?
Iwona Pawłowska, Grzegorz Ziółkowski, Estera Jachowicz, et al.
Microorganisms (2023) Vol. 11, Iss. 2, pp. 437-437
Open Access | Times Cited: 3
Iwona Pawłowska, Grzegorz Ziółkowski, Estera Jachowicz, et al.
Microorganisms (2023) Vol. 11, Iss. 2, pp. 437-437
Open Access | Times Cited: 3
Antibióticos en desarrollo para bacilos gram negativos multirresistentes
Alejandro Rodríguez, Antonio Moreno, M. Bodi, et al.
Medicina Intensiva (2022) Vol. 46, Iss. 11, pp. 630-640
Closed Access | Times Cited: 5
Alejandro Rodríguez, Antonio Moreno, M. Bodi, et al.
Medicina Intensiva (2022) Vol. 46, Iss. 11, pp. 630-640
Closed Access | Times Cited: 5
Meropenem/Vaborbactam and Cefiderocol as Combination or Monotherapy to Treat Multi-Drug Resistant Gram-Negative Infections: A Regional Cross-Sectional Survey from Piedmont Infectious Disease Unit Network (PIDUN)
Tommaso Lupia, Silvia Corcione, Nour Shbaklo, et al.
Journal of Functional Biomaterials (2022) Vol. 13, Iss. 4, pp. 174-174
Open Access | Times Cited: 5
Tommaso Lupia, Silvia Corcione, Nour Shbaklo, et al.
Journal of Functional Biomaterials (2022) Vol. 13, Iss. 4, pp. 174-174
Open Access | Times Cited: 5
Molecular characterization and descriptive analysis of carbapenemase-producing Gram-negative rod infections in Bogota, Colombia
Elsa D. Ibáñez-Prada, Ingrid G. Bustos, Enrique Gamboa-Silva, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 6
Open Access
Elsa D. Ibáñez-Prada, Ingrid G. Bustos, Enrique Gamboa-Silva, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 6
Open Access
The role of aztreonam in rational antibacterial therapy of resistant nosocomial gram-negative infections. The new life for a well-known β-lactam
V.А. Коrsunov, Marine Georgiyants, N.I. Zozulia, et al.
EMERGENCY MEDICINE (2024) Vol. 20, Iss. 3, pp. 174-179
Open Access
V.А. Коrsunov, Marine Georgiyants, N.I. Zozulia, et al.
EMERGENCY MEDICINE (2024) Vol. 20, Iss. 3, pp. 174-179
Open Access
